Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CTLT

Catalent (CTLT) Stock Price, News & Analysis

Catalent logo

About Catalent Stock (NYSE:CTLT)

Advanced Chart

Key Stats

Today's Range
$63.48
$63.48
50-Day Range
$59.66
$63.48
52-Week Range
$56.25
$63.50
Volume
N/A
Average Volume
2.04 million shs
Market Capitalization
$11.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.50
Consensus Rating
Hold

Company Overview

Catalent Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

CTLT MarketRank™: 

Catalent scored higher than 21% of companies evaluated by MarketBeat, and ranked 859th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Catalent has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Catalent has received no research coverage in the past 90 days.

  • Read more about Catalent's stock forecast and price target.
  • Earnings Growth

    Earnings for Catalent are expected to grow by 73.08% in the coming year, from $0.78 to $1.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Catalent has a PEG Ratio of 2.69. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Catalent has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTLT.
  • Dividend Yield

    Catalent does not currently pay a dividend.

  • Dividend Growth

    Catalent does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CTLT.
    Receive CTLT Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter.

    CTLT Stock News Headlines

    Trump set to Boost Social Security Checks by 400%?
    If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
    Lisata Therapeutics signs research license with Catalent
    Catalent Announces New Board Appointments
    See More Headlines

    CTLT Stock Analysis - Frequently Asked Questions

    Catalent, Inc. (NYSE:CTLT) issued its quarterly earnings results on Tuesday, November, 5th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of $0.05 by $0.18. The firm's quarterly revenue was up 4.2% compared to the same quarter last year.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Catalent investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

    Company Calendar

    Last Earnings
    11/05/2024
    Today
    7/02/2025
    Fiscal Year End
    6/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NYSE
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NYSE:CTLT
    Employees
    16,900
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $63.50
    High Stock Price Target
    $63.50
    Low Stock Price Target
    $63.50
    Potential Upside/Downside
    +0.0%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    4 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    81.38
    P/E Growth
    2.69
    Net Income
    -$1.04 billion
    Pretax Margin
    -7.83%

    Debt

    Sales & Book Value

    Annual Sales
    $4.38 billion
    Cash Flow
    $2.64 per share
    Price / Cash Flow
    24.04
    Book Value
    $19.91 per share
    Price / Book
    3.19

    Miscellaneous

    Free Float
    180,949,000
    Market Cap
    $11.52 billion
    Optionable
    Optionable
    Beta
    1.15

    Social Links

    Elon Musk's Next Move Cover

    Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

    Get This Free Report

    This page (NYSE:CTLT) was last updated on 7/2/2025 by MarketBeat.com Staff
    From Our Partners